Clinical Trial

Evaluation of the Efficacy of an Innovative Digital Therapeutic Medical Device, Lyv Endo, for the Management of Patients With Endometriosis

Study acronym: LYVENDO
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The main objective of this clinical study is to evaluate the clinical impact of using an innovative digital therapeutic device on the quality of life of patients with endometriosis. The working hypothesis is that the therapeutic digital medical device Lyv Endo may improve quality of life and reduce symptom intensity by enhancing patient engagement in the management of their condition. This justifies the need to evaluate the effect of Lyv Endo as a complement to standard medical care.
Protocol Amendment History 3 changes
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-06-09
notable Primary completion pushed: 2026-08-31 -> 2026-09-30 2026-06-09
minor Completion pushed: 2026-08-31 -> 2026-09-30 2026-06-09
Trial Details
NCT Number NCT07175857
Lead Sponsor Lyv Healthcare
Conditions Endometriosis
Enrollment 400 participants
Start Date 2025-07-21
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-08